Sutedja, Jane Carissa
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Knowledge Level of COVID-19 Prevention in Banjar Gambang Communities, Seraya Village, Karangasem, Indonesia Sasmana, I Gede Aswin Parisya; Wihandani, Desak Made; Halim, Wilson; Jaya, Ni Komang Ayu Amanda Setiari; Atmaja, Made Ayu Kurniati; Edgar, Christine; Sutedja, Jane Carissa; Mamangdean, Christo Timothy; Wijaya, Grace Veronika; Kusumadewi, Made Dea Avrilia
Althea Medical Journal Vol 10, No 2 (2023)
Publisher : Faculty of Medicine Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15850/amj.v10n2.2857

Abstract

Background: Problems to COVID-19 are closely related to the level of knowledge and community prevention. Therefore, to overcome COVID-19, increased knowledge and prevention are needed. This study aimed to evaluate the correlation between prevention and knowledge level about COVID-19.Methods: A cross-sectional study using a convenience sampling approach was conducted in Banjar Gambang, Karangasem, Indonesia, in April 2022. The knowledge level and preventive behavior towards COVID-19 were measured using the COVID-19 Preventive Behaviors Index (CPBI) and the knowledge, attitudes, and practice toward COVID-19 (KAPCOV-19) questionnaire. The data were analyzed using SPSS software version 26.0.Results: A total of 52 respondents were included, who had excellent level of knowledge (44.2%) and moderate prevention behaviour (48.1%). A strong and significant correlation was found between the preventive index and the knowledge levels of COVID-19 (r = 0.548; p<0.001). The level of knowledge was significantly related to the level of preventive behavior (p= 0.003), as well as the education level (r = 0.323; p = 0.02) and age (r= -0.346; p=0.012).Conclusion: The level of knowledge and the individual prevention behavior toward COVID-19 are directly proportional to each other. Those who have a low level of knowledge, might affect their prevention behavior toward COVID-19, therefore, personalized socialization of COVID-19 prevention is still required.
Maternal-related factors associated with development and improvement of peripartum cardiomyopathy and therapeutic outcomes of bromocriptine Pradnyaandara, I Gusti Bagus Mulia Agung; Mulyana, Ryan Saktika; Sutedja, Jane Carissa; Jagannatha, Gusti Ngurah Prana; Wibawa, I Bagus Satriya; Deantri, Fanny; Pradnyana, I Wayan Agus Surya; de Liyis, Bryan Gervais
Majalah Obstetri & Ginekologi Vol. 32 No. 2 (2024): August
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/mog.V32I22024.112-127

Abstract

HIGHLIGHTS Younger age, black race, normotension, and multiparity indicate a poorer prognosis for peripartum cardiomyopathy recovery, while bromocriptine therapy reduces adverse events.   ABSTRACT Objectives: This study aimed to fill the significant knowledge gap regarding peripartum cardiomyopathy (PPCM), a heart failure phenotype linked to pregnancy. The main objectives were to explore the factors influencing the development and progression of PPCM and to assess the outcomes of bromocriptine.Materials and Methods: Systematic search across PubMed, ScienceDirect, and Cochrane Library identified studies until December 2022. This study includes non-randomized prospective and retrospective studies, as well as relevant randomized controlled trials. Risk factors were compared between the recovered and non-recovered PPCM groups, and bromocriptine therapy outcomes were evaluated against standard heart failure treatment as the primary endpoint.Results: The analysis included 24 observational studies and 1 randomized controlled trial involving 1,651 PPCM patients; 9 studies evaluating the outcomes of bromocriptine therapy. The most prevalent factors were caesarean delivery (proportion=53%, 95%CI=41%-66%) and anemia (proportion=51%, 95%CI=38%-65%). Non-recovered patients were younger (MD=-1.04 years old, 95%CI=-1.82-(-0.27), p=0.008) and predominantly black (RR=1.82, 95%CI=1.43-2.31, p <0.001). Hypertensive disorders and primiparity were found less among non-recovered patients (RR=0.73, 95%CI=0.60-0.88, p=0.001; RR=0.81, 95%CI=0.66-0.99, p=0.04, respectively). Non-recovered patients also exhibited higher baseline serum creatinine levels, lower LVEF, larger left ventricular end-systolic diameter (LVESD), larger left ventricular end-diastolic diameter (LVEDD), and lower fractional shortening (all P-values<0.05). Furthermore, bromocriptine significantly reduced major adverse cardiac events (MACE), mortality, and increased LVEF (all P-values<0.05).Conclusion: Younger maternal age, black race, absence of hypertension, and multiparity are associated with poorer prognosis for PPCM recovery. Bromocriptine therapy demonstrates superior benefits in reducing adverse events in PPCM.